Another thought Ego, we are already partnered with BMS on the SEGLIN portfolio, maybe they are one of the several interested parties! It's worth a read of their partnering page and they are flush with cash!
There's always interested parties and every CEO believes he has the best drug.
Sorry to burst your bubble but Glyn won't get VC funding in the City (what a dated phrase) they don't fund high risk pharma's with no revenue streams and if they did they would want a huge chunk of equity.
Funding would have to come from a collaboration of some sort, most likely with a large pharma company, or a Placing.
Time to come back to the real world and not the land of make believe.
Absolutely Ego, it really doesn't matter what price you buy at around these level in my opinion. If you've done your research, and am prepared to take the gamble on this little biotech delivering what it potentially could, then any stock bought at these prices will give you a very very good return.
Before a placing we need to answer the RDZ deal question. But if the answer is that it cannot be done at fair value right now then I get the impression many current PI's would be happy with a… Read More
Actually Monday's top-up doesn't look so bad now :) My view was and is that we don't necessarily need news to see SP growth - just more people digging into the numbers - so the more we are discussed in the same breath as Sarepta the better.
I'm also not overly concerned about funding, because barring a complete catastrophe it's going to happen one way or another. Even a highly dilutive placement means very little if the drug works.
My average is still something like £1.60 - My… Read More
You are most definitely entitled to your view and I welcome it because it keeps matters level and balanced
It's just a question of delivery and encouraging some open discussion rather than scathing attacks back and forth that contribute zero in terms of helping investors become more informed on their investments
I share your concern over funding. I don't have any further money to invest currently ... so I am just sitting here and hoping that it will come good
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.